Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 2c, Guidance Tops Views

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of $, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $246.6 million versus the consensus estimate of $245.82 million.

GUIDANCE:

Hims & Hers Health, Inc. sees Q1 2024 revenue of $267-272 million, versus the consensus of $251 million.

• Adjusted EBITDA of $22 million to $27 million, reflecting an Adjusted EBITDA margin of 8% to 10%.

Hims & Hers Health, Inc. sees FY2024 revenue of $1.17-1.2 billion, versus the consensus of $1.1 billion.

• Adjusted EBITDA of $100 million to $120 million, reflecting an Adjusted EBITDA margin of 9% to 10%.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Robinhood plans $2B convertible notes offering due 2029
• Tutor Perini launches $400M senior notes offering due 2033